Alavert and Diovan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alavert (loratadine) and Diovan (valsartan). Common drug interactions include malaise among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Alavert and Diovan. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Alavert?

Alavert has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 2,062 Alavert users. Check the latest studies of Alavert.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,153 Diovan users. Check the latest studies of Diovan.



On Jul, 14, 2026

33 people who take Alavert and Diovan together, and have interactions are studied.

Alavert and Diovan drug interactions.

What are the common drug interactions of Alavert and Diovan, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Anxiety
  3. Injury
  4. Nausea (feeling of having an urge to vomit)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bradycardia (abnormally slow heart action)
  7. Decreased appetite
  8. Drug effect decreased
  9. Emotional disorder
  10. Stress

male:

  1. Abdominal discomfort
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Fatigue (feeling of tiredness)
  4. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Ulcer haemorrhage (bleeding ulcer)
  8. Drug intolerance (drug sensitivity)
  9. Hypotension (abnormally low blood pressure)
  10. Increased appetite

What are the common drug interactions of Alavert and Diovan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Pain
  3. Diarrhoea
  4. Erythema (redness of the skin)
  5. Fatigue (feeling of tiredness)
  6. Skin discolouration (change of skin colour)
  7. Anxiety
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

50-59:

  1. Throat tightness
  2. Dizziness
  3. Nausea (feeling of having an urge to vomit)
  4. Salivary hypersecretion (excess saliva secretion)
  5. Stomach discomfort (pain in abdomen)

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Anxiety
  3. Drug ineffective
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Pyrexia (fever)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Asthenia (weakness)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Headache (pain in head)
  10. Joint injury

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 7 people, 21.21%
  2. Rhinorrhea (watery mucus discharge from the nose): 5 people, 15.15%
  3. Cardiac Disorder: 5 people, 15.15%
  4. Sneezing: 4 people, 12.12%
  5. Blood Pressure Abnormal: 4 people, 12.12%
  6. Pain: 3 people, 9.09%
  7. Nasopharyngitis (inflammation of the nasopharynx): 3 people, 9.09%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 9.09%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 9.09%
  10. Hypersensitivity: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Alavert and Diovan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alavert and Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alavert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alavert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diovan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and valsartan (the active ingredients of Alavert and Diovan, respectively), and Alavert and Diovan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: